{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:30:44Z","timestamp":1790681444002,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,14]]},"DOI":"10.1097\/qad.0b013e328341dd68","type":"journal-article","created":{"date-parts":[[2010,12,11]],"date-time":"2010-12-11T07:32:51Z","timestamp":1292052771000},"page":"F1-F6","source":"Crossref","is-referenced-by-count":26,"title":["Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy"],"prefix":"10.1097","volume":"25","author":[{"given":"Sugato","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Allen","family":"McCutchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau M","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia K","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.44.10.1892","article-title":"Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS Cohort Study, 1985\u20131992","volume":"44","author":"Bacellar","year":"1994","journal-title":"Neurology"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.21484","article-title":"Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy","volume":"64","author":"Ellis","year":"2008","journal-title":"Ann Neurol"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.56.1.84","article-title":"Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings","volume":"56","author":"Tagliati","year":"1999","journal-title":"Arch Neurol"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","article-title":"Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy","volume":"52","author":"Childs","year":"1999","journal-title":"Neurology"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.0b013e3181af7a22","article-title":"Age and height predict neuropathy risk in patients with HIV prescribed stavudine","volume":"73","author":"Cherry","year":"2009","journal-title":"Neurology"},{"key":"R8-1-20210130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1464-5491.2004.01124.x","article-title":"Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes","volume":"21","author":"Costa","year":"2004","journal-title":"Diabet Med"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000109826","article-title":"HIV-related peripheral neuropathy and glucose dysmetabolism: study of a public dataset","volume":"29","author":"Sheth","year":"2007","journal-title":"Neuroepidemiology"},{"key":"R10-1-20210130","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1097\/QAD.0b013e328332204e","article-title":"Role of metabolic syndrome components in HIV-associated sensory neuropathy","volume":"23","author":"Ances","year":"2009","journal-title":"AIDS"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.HYP.0000250557.63490.55","article-title":"Effectiveness of blood pressure control outside the medical setting","volume":"49","author":"Banegas","year":"2007","journal-title":"Hypertension"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.0000150859.47929.8e","article-title":"Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research","volume":"45","author":"Pickering","year":"2005","journal-title":"Hypertension"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/01.ATV.17.10.1910","article-title":"Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males","volume":"17","author":"Cuchel","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/157016208786501481","article-title":"Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors","volume":"6","author":"Calza","year":"2008","journal-title":"Curr HIV Res"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s001250100615","article-title":"The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes","volume":"44","author":"Isomaa","year":"2001","journal-title":"Diabetologia"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.wco.0000073943.19076.98","article-title":"Recent developments in the HIV neuropathies","volume":"16","author":"Luciano","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.24.13.1194.38084","article-title":"Statin-associated peripheral neuropathy: review of the literature","volume":"24","author":"Chong","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/01.wnl.0000264888.87918.a1","article-title":"Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy","volume":"68","author":"Zhou","year":"2007","journal-title":"Neurology"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/15216540601178091","article-title":"Mitochondrial energy metabolism and redox state in dyslipidemias","volume":"59","author":"Vercesi","year":"2007","journal-title":"IUBMB Life"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/er.2003-0019","article-title":"Oxidative stress in the pathogenesis of diabetic neuropathy","volume":"25","author":"Vincent","year":"2004","journal-title":"Endocr Rev"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.2337\/db09-0047","article-title":"Dyslipidemia-induced neuropathy in mice: the role of oxLDL\/LOX-1","volume":"58","author":"Vincent","year":"2009","journal-title":"Diabetes"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/db08-1771","article-title":"Elevated triglycerides correlate with progression of diabetic neuropathy","volume":"58","author":"Wiggin","year":"2009","journal-title":"Diabetes"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1373\/clinchem.2007.097907","article-title":"Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?","volume":"54","author":"Ridker","year":"2008","journal-title":"Clin Chem"},{"key":"R26-1-20210130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e328341dd68","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:32:08Z","timestamp":1620970328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201101140-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328341dd68","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}